CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.

Clinical lymphoma, myeloma & leukemia(2022)

引用 0|浏览0
暂无评分
摘要
Winship Cancer Institute and Emory University Institutional Funds, NCI U54 CA260563, P30CA138292, NIH P51 OD011132, HHSN272201400004C, U19AI090023, R35CA197603.
更多
查看译文
关键词
CLL,COVID-19,SARS-CoV-2,chronic lymphocytic leukemia,non-Hodgkin lymphoma,vaccine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要